Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance
Abstract Background Glioblastoma (GBM) patients frequently develop resistance to temozolomide (TMZ), the standard chemotherapy. While targeting cancer metabolism shows promise, the relationship between metabolic perturbation and drug resistance remains poorly understood. Methods We performed high-th...
Saved in:
| Main Authors: | Xing Li, Wansong Zhang, Yitong Fang, Tianhu Sun, Jian Chen, Ruilin Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06261-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to Artesunate
by: Olivier Switzeny, et al.
Published: (2025-06-01) -
Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
by: Diego Carrillo-Beltrán, et al.
Published: (2025-01-01) -
Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01) -
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment
by: Gilbert Aaron Lee, et al.
Published: (2025-03-01) -
Efficacy of D,L-methadone in the treatment of glioblastoma in vitro
by: Konstantin Brawanski, et al.
Published: (2018-07-01)